Multiple Myeloma
The AJMC® Multiple Myeloma compendium is a comprehensive resource for clinical news and expert insights for this cancer.
Cost-Effectiveness Strategies Vital for Streamlining Care in Hematologic Malignancies
Optimizing Approaches to CAR T, Bispecific Therapies in Myeloma and Lymphoma
Honoring Patient Wishes in Myeloma Treatment Journeys
Using MRD, Patient Preference to Optimize Multiple Myeloma Care
Unlocking Myeloma Outcomes: The Role of Immunity
How Anti–CD-38 Antibodies Are Changing the Standard of Myeloma Care
Balancing Cutting-Edge Therapies With Cost in Multiple Myeloma Treatment
Transforming Multiple Myeloma Care With Education and Advanced Therapies
MRD: A Game Changer in Multiple Myeloma
IMS 2024 Speakers Look Back on Exciting Myeloma Updates
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy
Closing Gaps in CLL Care: Managed Care Insights and Strategies
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care
More News
Evaluating T-Cell Therapies in First-Line Multiple Myeloma Treatment
